| 摘要 |
The present invention relates to glycodelin for use in the diagnosis, prognosis and/or treatment monitoring of a lung disease. The present invention further relates to a method for the diagnosis, prognosis and/or treatment monitoring of a lung disease, comprising the step of determining the presence of glycodelin in serum, plasma and/or tissue. The present invention further relates to glycodelin for use in modulating the immune system in subjects with lung transplantation, preferably in order to prevent organ recipient from allograft rejection, comprising treatment of the lung with glycodelin before, during and/or after said lung transplantation and a respective method. |
